No data available.
Please log in to see this content.
You have no subscription access to this content.
The full text of this article is not currently available.
Characteristics and Economic Effects of Prescription Audits Conducted Because of Unused Medicines―Analysis of Pharmaceutical Intervention Records―
Rent:
Rent this article for
JPY
Abstract
Through the Pharmaceutical Intervention Record(PIR)project jointly conducted by the Gifu Pharmaceutical Association and Gifu Pharmaceutical University, we analyzed characteristics and economic effects of prescription audits initiated because of prescription inquiries about unused medicines. Before analysis, 1105 prescriptions reported in fiscal 2017 were divided into prescriptions with unused medicines(the unused group)and other prescriptions(the control group). The amount of reduced drug cost per prescription in the unused group was 1625 yen, which was significantly larger than 906 yen in the control group. In the unused group, unused drugs were found by checking drugs bought by the patients as well as by communicating with patients and their family members, and the number of days prescribed was changed or the prescribed drug was canceled more commonly after audits. These prescription changes are likely to be the reason for the larger decrease in the drug cost in the unused group than in the control group. The classification of drugs based on efficacy that was often adjusted because of unused medicines included sedative and hypnotic agents/laxative agents, vasodilator agents, and herbal medicines.
Full text loading...
/content/article/0386-3603/47120/1985